Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.
about
Silencing of hepatitis A virus infection by small interfering RNAsAssessment of vaccine candidates for persons aged 50 and older: a review.Physicians infrequently adhere to hepatitis vaccination guidelines for chronic liver disease.Immunogenicity of Twinrix in older adults: a critical analysis.Polio vaccines and the cessation of vaccination.Prevention of hepatitis A by vaccination.Hepatitis A Virus among Drug Users and the Role of Vaccination: A ReviewPrevention of hepatitis A by Havrix: a review.Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States.Pattern of Hepatitis A Virus Epidemiology in Nursing Students and Adherence to Preventive Measures at Two Training Wards of a University HospitalInduction of mucosal immunity through systemic immunization: Phantom or reality?Bloodborne viral hepatitis infections among drug users: the role of vaccinationComparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up studyComparison of Immunogenicity Between Inactivated and Live Attenuated Hepatitis A Vaccines Among Young Adults: A 3-Year Follow-up Study.Trends in disease and complications of hepatitis A virus infection in the United States, 1999-2011: a new concern for adults.Seroprotection after hepatitis a vaccination in patients with drug-induced immunosuppression.Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.Letter to the Editor in Response to the Editorial Commentary by Dr Kenrad E. Nelson Entitled, "The Changing Epidemiology of Hepatitis A Virus Infections in the United States".Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine.Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.Response to hepatitis A vaccine in HIV-positive patients.
P2860
Q24545889-465A5B61-1A27-4AC5-B590-65CCA596EF03Q34668826-023C38E4-02CA-4D3A-BEE0-038435C55460Q34907938-10D7A286-0FAD-45D1-8658-4EF829C418F0Q35193521-458394D6-1DD8-4789-A253-25E15E46799AQ35193552-054D66EB-C29C-42DA-A6BC-5F01FD85B98EQ35207528-BC47E8A8-310B-42FC-8B4A-D63B68BF76C1Q35747360-CF5105C6-1555-4A94-B0A7-8AACF49B48D0Q36238689-ED7ED218-C52E-4553-8086-73BBB405041DQ36849799-511AB8ED-1AB1-4D66-A06B-E92FC0790030Q36901395-CC026A29-690E-4348-A5A8-C6B222DD4DA0Q36902448-A852BF8A-5329-4FDF-94E6-D27C88F347D1Q37130744-03A102D3-5B5B-4D0D-9A0E-CD6D7ADC6F2BQ37167103-48AF4460-B50D-4121-A5F7-1767149DAB95Q37375908-897B0CD7-D2EF-4342-ADDE-E6FAAB7DF9FCQ41235777-EE06DA5D-43BA-49E8-B0A3-616C16ABC235Q41503350-B96762FD-C4B5-428A-A6A1-F4AEA4EFACD1Q42249242-95DEFB0A-B116-49C0-BC6E-27C7D720E794Q42267455-9E6B68A6-D83B-4C08-B38D-328AD9EF0F56Q45203258-EC076BC0-8346-40C0-A914-6FF455654A4AQ50968259-0C8C5974-2E09-4B57-A4CA-5A4BECB81BDBQ50992687-D0F253FF-D039-465A-8BA1-8131B305B264Q51822029-B2195BA2-8342-4220-A287-D500519095B7
P2860
Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inactivated hepatitis A vaccin ...... icial recommendations for use.
@ast
Inactivated hepatitis A vaccin ...... icial recommendations for use.
@en
type
label
Inactivated hepatitis A vaccin ...... icial recommendations for use.
@ast
Inactivated hepatitis A vaccin ...... icial recommendations for use.
@en
prefLabel
Inactivated hepatitis A vaccin ...... icial recommendations for use.
@ast
Inactivated hepatitis A vaccin ...... icial recommendations for use.
@en
P2093
P2860
P356
P1476
Inactivated hepatitis A vaccin ...... icial recommendations for use.
@en
P2093
Assad Safary
Francis André
Jangu Banatvala
P2860
P356
10.1586/14760584.1.1.9
P577
2002-06-01T00:00:00Z